Hsieh Li-Chi, Wu Wen-Chao, Tseng Shu-Hui
Division of Infection Control and Biosafety, Taiwan Centers for Disease Control, Ministry of Health and Welfare, Taipei City, Taiwan.
Appl Biosaf. 2021 Sep 1;26(3):123-129. doi: 10.1089/apb.19.0045. Epub 2021 Sep 13.
Before 2016, there were no specific regulations or guidelines for the management of biological select agents and toxins (BSATs) in Taiwan. The Taiwan Centers for Disease Control responded to the global health security agenda in 2016 and made use of the Joint External Evaluation tool: International Health Regulations to evaluate Taiwan's epidemic prevention system capacities, including BSAT management. For technical areas that did not meet the highest requirements, the regulations and guidelines are now in place to strengthen the management of BSATs. In 2017, a survey on the BSAT entities management status in Taiwan was conducted to understand the gap between BSAT practice and international policies, and to improve BSAT management based on the findings. After 3 years of promotion, relevant management regulations and supervision mechanisms have been established. In 2021, the evaluation will be conducted again and it is expected that Taiwan's BSAT management capacity will reach the level of international biosafety and biosecurity.
2016年以前,台湾地区对于生物选择剂和毒素(BSATs)的管理没有具体的法规或指南。台湾疾病管制中心于2016年响应全球卫生安全议程,并利用联合外部评估工具:《国际卫生条例》来评估台湾地区的防疫系统能力,包括BSATs管理。对于未达到最高要求的技术领域,现已制定法规和指南以加强BSATs的管理。2017年,台湾地区开展了一项关于BSATs实体管理状况的调查,以了解BSATs实践与国际政策之间的差距,并根据调查结果改进BSATs管理。经过3年的推广,已建立了相关管理法规和监督机制。2021年将再次进行评估,预计台湾地区的BSATs管理能力将达到国际生物安全和生物安保水平。